Analysis of Profitability Ratios
Quarterly Data
Beginner level
Profitability ratios measure the company’s ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Danaher Corp., profitability ratios (quarterly data)
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-10-22), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-23).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Danaher Corp.’s gross profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Danaher Corp.’s operating profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Danaher Corp.’s net profit margin ratio improved from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Danaher Corp.’s ROE improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Danaher Corp.’s ROA deteriorated from Q4 2019 to Q1 2020 but then improved from Q1 2020 to Q2 2020 exceeding Q4 2019 level. |
Gross Profit Margin
Danaher Corp., gross profit margin calculation (quarterly data)
| Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Gross profit | 2,852,600 | 2,442,800 | 2,336,600 | 2,808,400 | 2,483,800 | 2,354,900 | 2,955,900 | 2,690,500 | 2,817,100 | 2,643,600 | 2,839,100 | 2,536,800 | 2,482,300 | 2,334,300 | 2,500,000 | 2,286,000 | 2,381,300 | 2,167,300 | 3,013,300 | 2,637,000 | 2,644,000 | 2,468,200 | |||||||
| Sales | 5,297,400 | 4,343,100 | 4,209,100 | 5,037,300 | 4,444,500 | 4,220,200 | 5,363,500 | 4,853,100 | 4,981,000 | 4,695,400 | 5,085,700 | 4,528,200 | 4,510,100 | 4,205,700 | 4,584,300 | 4,132,100 | 4,241,900 | 3,924,100 | 5,884,800 | 5,023,400 | 4,960,200 | 4,694,700 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Gross profit margin1 | 55.28% | 55.85% | 55.74% | 55.61% | 55.53% | 55.71% | 55.83% | 56.03% | 56.18% | 55.80% | 55.61% | 55.27% | 55.09% | 55.36% | 55.29% | 54.16% | 53.47% | 52.86% | 52.34% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Gross Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 46.24% | 47.78% | 47.94% | 47.42% | 47.28% | 45.04% | 45.44% | 45.60% | 46.00% | 49.30% | 49.14% | 48.86% | 48.57% | 48.59% | 47.99% | 47.66% | 44.92% | 45.09% | 45.66% | 46.34% | 50.87% | 50.83% | |||||||
| Boston Scientific Corp. | 68.26% | 70.41% | 70.98% | 71.20% | 71.33% | 71.12% | 71.37% | 71.48% | 71.35% | 71.78% | 71.34% | 71.27% | 71.38% | 70.86% | 71.09% | 70.88% | 70.78% | 70.99% | 70.94% | — | — | — | |||||||
| Intuitive Surgical Inc. | 67.07% | 69.04% | 69.45% | 69.45% | 69.47% | 69.60% | 69.92% | 70.07% | 70.22% | 70.31% | 70.12% | 69.75% | 69.97% | 70.08% | 69.89% | 69.42% | 68.38% | 67.28% | 66.18% | — | — | — | |||||||
| Medtronic PLC | 69.22% | 69.62% | 70.04% | 70.33% | 70.40% | 70.25% | 69.77% | 69.40% | 69.05% | 68.67% | 68.73% | 68.60% | 68.66% | 68.85% | 68.29% | 66.00% | 66.48% | 67.07% | 68.86% | — | — | — | |||||||
| Stryker Corp. | 63.34% | 65.15% | 65.14% | 64.95% | 65.29% | 65.47% | 65.72% | 65.69% | 65.55% | 65.58% | 65.68% | 66.12% | 66.16% | 65.87% | 66.18% | 66.42% | 66.67% | 67.01% | 66.38% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 45.39% | 44.30% | 44.35% | 44.48% | 44.51% | 44.60% | 44.57% | 44.36% | 44.55% | 44.68% | 45.15% | 45.67% | 45.88% | 45.90% | 45.80% | 45.62% | 45.60% | 45.51% | 45.72% | — | — | — | |||||||
| UnitedHealth Group Inc. | 25.95% | 23.52% | 23.19% | 22.92% | 22.89% | 23.15% | 23.33% | 23.36% | 23.33% | 23.28% | 22.98% | 23.09% | 23.12% | 22.99% | 23.13% | 22.35% | 22.20% | 22.73% | 23.22% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-10-22), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-23).
1 Q2 2020 Calculation
Gross profit margin = 100
× (Gross profitQ2 2020
+ Gross profitQ1 2020
+ Gross profitQ4 2019
+ Gross profitQ3 2019)
÷ (SalesQ2 2020
+ SalesQ1 2020
+ SalesQ4 2019
+ SalesQ3 2019)
= 100 × (2,852,600 + 2,442,800 + 2,336,600 + 2,808,400)
÷ (5,297,400 + 4,343,100 + 4,209,100 + 5,037,300)
= 55.28%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Danaher Corp.’s gross profit margin ratio improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Operating Profit Margin
Danaher Corp., operating profit margin calculation (quarterly data)
| Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Operating profit | 844,600 | 697,500 | 903,200 | 834,800 | 811,700 | 719,700 | 962,600 | 830,700 | 867,500 | 743,000 | 946,100 | 767,500 | 683,700 | 623,900 | 728,600 | 699,100 | 710,100 | 613,100 | 978,800 | 800,800 | 934,400 | 755,100 | |||||||
| Sales | 5,297,400 | 4,343,100 | 4,209,100 | 5,037,300 | 4,444,500 | 4,220,200 | 5,363,500 | 4,853,100 | 4,981,000 | 4,695,400 | 5,085,700 | 4,528,200 | 4,510,100 | 4,205,700 | 4,584,300 | 4,132,100 | 4,241,900 | 3,924,100 | 5,884,800 | 5,023,400 | 4,960,200 | 4,694,700 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Operating profit margin1 | 17.37% | 18.01% | 18.25% | 17.46% | 17.61% | 17.41% | 17.11% | 17.27% | 17.23% | 16.69% | 16.48% | 15.73% | 15.69% | 16.09% | 16.29% | 16.51% | 16.27% | 16.81% | 16.87% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Operating Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 9.23% | 7.91% | 10.18% | 12.98% | 12.37% | 12.63% | 9.37% | 9.29% | 4.69% | 7.32% | 12.22% | 9.29% | 15.17% | 15.21% | 11.46% | 13.23% | 10.22% | 9.60% | 10.45% | 12.53% | 17.60% | 18.59% | |||||||
| Boston Scientific Corp. | 6.58% | 10.41% | 14.14% | 15.66% | 16.19% | 16.50% | 15.33% | 15.57% | 15.74% | 14.33% | 14.20% | 12.53% | 12.36% | 6.04% | 5.33% | 0.44% | -7.68% | -0.76% | -4.37% | — | — | — | |||||||
| Intuitive Surgical Inc. | 25.86% | 30.52% | 30.69% | 30.82% | 31.10% | 30.51% | 32.21% | 33.46% | 33.56% | 34.52% | 33.71% | 33.14% | 33.79% | 34.40% | 34.95% | 35.32% | 33.99% | 32.23% | 31.04% | — | — | — | |||||||
| Medtronic PLC | 20.47% | 21.25% | 20.51% | 20.48% | 20.22% | 21.70% | 22.20% | 21.35% | 20.47% | 18.55% | 17.94% | 17.72% | 18.65% | 18.54% | 18.35% | 14.56% | 15.72% | 16.37% | 18.59% | — | — | — | |||||||
| Stryker Corp. | 15.54% | 18.86% | 18.23% | 16.96% | 17.00% | 17.83% | 18.65% | 19.22% | 19.16% | 18.28% | 18.40% | 18.46% | 18.42% | 18.68% | 19.13% | 19.78% | 19.53% | 19.62% | 18.71% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 17.05% | 17.86% | 17.99% | 17.88% | 18.00% | 15.90% | 15.53% | 15.03% | 14.36% | 14.23% | 14.19% | 13.94% | 13.89% | 13.62% | 13.40% | 13.28% | 13.68% | 13.65% | 13.77% | — | — | — | |||||||
| UnitedHealth Group Inc. | 9.89% | 8.12% | 8.19% | 8.02% | 7.97% | 7.88% | 7.71% | 7.70% | 7.68% | 7.67% | 7.60% | 7.37% | 7.26% | 7.11% | 7.03% | 6.78% | 6.64% | 6.87% | 7.05% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-10-22), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-23).
1 Q2 2020 Calculation
Operating profit margin = 100
× (Operating profitQ2 2020
+ Operating profitQ1 2020
+ Operating profitQ4 2019
+ Operating profitQ3 2019)
÷ (SalesQ2 2020
+ SalesQ1 2020
+ SalesQ4 2019
+ SalesQ3 2019)
= 100 × (844,600 + 697,500 + 903,200 + 834,800)
÷ (5,297,400 + 4,343,100 + 4,209,100 + 5,037,300)
= 17.37%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Danaher Corp.’s operating profit margin ratio deteriorated from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Net Profit Margin
Danaher Corp., net profit margin calculation (quarterly data)
| Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Net earnings attributable to Danaher stockholders | 927,300 | 595,100 | 1,275,100 | 668,000 | 731,300 | 333,800 | 746,800 | 663,700 | 673,800 | 566,600 | 856,600 | 572,100 | 557,300 | 506,100 | 747,000 | 391,600 | 656,700 | 758,400 | 688,600 | 1,403,300 | 695,700 | 569,800 | |||||||
| Sales | 5,297,400 | 4,343,100 | 4,209,100 | 5,037,300 | 4,444,500 | 4,220,200 | 5,363,500 | 4,853,100 | 4,981,000 | 4,695,400 | 5,085,700 | 4,528,200 | 4,510,100 | 4,205,700 | 4,584,300 | 4,132,100 | 4,241,900 | 3,924,100 | 5,884,800 | 5,023,400 | 4,960,200 | 4,694,700 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| Net profit margin1 | 18.35% | 18.13% | 16.80% | 13.01% | 13.11% | 12.45% | 13.33% | 14.07% | 13.84% | 13.56% | 13.60% | 13.36% | 12.63% | 13.41% | 15.13% | 13.72% | 18.39% | 17.92% | 16.33% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| Net Profit Margin, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 6.17% | 5.25% | 7.13% | 5.47% | 6.33% | 6.13% | 1.95% | 5.23% | 0.34% | 3.28% | 9.10% | 6.52% | 10.67% | 10.54% | 7.82% | 9.24% | 6.62% | 6.13% | 6.76% | 8.65% | 12.75% | 13.56% | |||||||
| Boston Scientific Corp. | 39.24% | 39.75% | 43.78% | 10.49% | 13.85% | 18.08% | 17.01% | 6.93% | 5.48% | 1.21% | 1.15% | 9.55% | 9.04% | 5.07% | 4.14% | 0.99% | -4.34% | -0.47% | -3.20% | — | — | — | |||||||
| Intuitive Surgical Inc. | 26.07% | 30.11% | 30.80% | 30.94% | 29.95% | 29.78% | 30.29% | 22.31% | 23.20% | 23.25% | 21.09% | 30.16% | 28.44% | 27.99% | 27.21% | 27.51% | 26.80% | 25.67% | 24.69% | — | — | — | |||||||
| Medtronic PLC | 15.11% | 14.41% | 15.16% | 16.10% | 7.44% | 10.56% | 10.36% | 9.44% | 16.93% | 13.75% | 13.56% | 13.51% | 14.62% | 12.70% | 12.27% | 8.52% | 8.92% | 11.28% | 13.20% | — | — | — | |||||||
| Stryker Corp. | 11.38% | 14.47% | 13.99% | 23.55% | 24.99% | 25.38% | 26.12% | 9.31% | 8.28% | 8.00% | 8.20% | 14.67% | 14.22% | 14.33% | 14.54% | 15.24% | 15.33% | 16.07% | 14.47% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 14.12% | 14.31% | 14.47% | 14.24% | 14.24% | 12.89% | 12.06% | 10.75% | 10.36% | 10.24% | 10.64% | 11.74% | 11.80% | 11.58% | 11.06% | 11.10% | 11.35% | 11.49% | 11.64% | — | — | — | |||||||
| UnitedHealth Group Inc. | 6.94% | 5.63% | 5.76% | 5.61% | 5.55% | 5.49% | 5.33% | 5.75% | 5.58% | 5.43% | 5.28% | 4.41% | 4.23% | 4.03% | 3.81% | 3.64% | 3.52% | 3.64% | 3.72% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-10-22), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-23).
1 Q2 2020 Calculation
Net profit margin = 100
× (Net earnings attributable to Danaher stockholdersQ2 2020
+ Net earnings attributable to Danaher stockholdersQ1 2020
+ Net earnings attributable to Danaher stockholdersQ4 2019
+ Net earnings attributable to Danaher stockholdersQ3 2019)
÷ (SalesQ2 2020
+ SalesQ1 2020
+ SalesQ4 2019
+ SalesQ3 2019)
= 100 × (927,300 + 595,100 + 1,275,100 + 668,000)
÷ (5,297,400 + 4,343,100 + 4,209,100 + 5,037,300)
= 18.35%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Danaher Corp.’s net profit margin ratio improved from Q4 2019 to Q1 2020 and from Q1 2020 to Q2 2020. |
Return on Equity (ROE)
Danaher Corp., ROE calculation (quarterly data)
| Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Net earnings attributable to Danaher stockholders | 927,300 | 595,100 | 1,275,100 | 668,000 | 731,300 | 333,800 | 746,800 | 663,700 | 673,800 | 566,600 | 856,600 | 572,100 | 557,300 | 506,100 | 747,000 | 391,600 | 656,700 | 758,400 | 688,600 | 1,403,300 | 695,700 | 569,800 | |||||||
| Total Danaher stockholders’ equity | 36,261,700 | 31,055,100 | 30,270,600 | 32,502,300 | 32,201,200 | 31,556,600 | 28,214,400 | 27,673,400 | 27,212,300 | 27,189,900 | 26,358,200 | 25,375,400 | 24,590,000 | 23,785,800 | 23,002,800 | 23,191,600 | 25,045,100 | 24,504,700 | 23,690,300 | 23,112,700 | 24,101,200 | 23,321,000 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| ROE1 | 9.56% | 10.53% | 9.94% | 7.63% | 7.69% | 7.66% | 9.40% | 9.98% | 9.81% | 9.39% | 9.45% | 9.39% | 8.95% | 9.68% | 11.10% | 10.76% | 14.00% | 14.47% | 14.17% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| ROE, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 5.13% | 4.30% | 5.85% | 4.35% | 5.06% | 4.89% | 1.48% | 3.61% | 0.22% | 1.89% | 8.50% | 6.30% | 16.51% | 17.26% | 12.79% | 14.17% | 10.57% | 9.53% | 9.70% | 11.24% | 15.07% | 22.69% | |||||||
| Boston Scientific Corp. | 25.53% | 31.06% | 33.87% | 11.24% | 14.81% | 19.46% | 19.15% | 8.08% | 6.73% | 1.59% | 1.48% | 11.11% | 10.89% | 6.17% | 5.15% | 1.25% | -5.55% | -0.56% | -3.78% | — | — | — | |||||||
| Intuitive Surgical Inc. | 13.00% | 16.30% | 16.69% | 16.93% | 16.65% | 16.33% | 16.89% | 12.68% | 13.68% | 13.97% | 13.97% | 18.21% | 18.05% | 18.88% | 12.74% | 13.03% | 13.09% | 13.22% | 13.63% | — | — | — | |||||||
| Medtronic PLC | 9.23% | 8.78% | 9.25% | 9.87% | 4.56% | 6.30% | 6.12% | 5.59% | 9.75% | 8.12% | 8.01% | 8.03% | 8.45% | 7.18% | 6.80% | 4.79% | 4.43% | 4.97% | 5.03% | — | — | — | |||||||
| Stryker Corp. | 12.55% | 16.50% | 16.26% | 27.82% | 29.72% | 30.12% | 30.29% | 12.54% | 11.42% | 11.06% | 10.23% | 17.06% | 16.94% | 17.41% | 17.25% | 17.78% | 17.64% | 18.36% | 16.91% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 12.41% | 12.85% | 12.45% | 12.24% | 12.33% | 11.46% | 10.65% | 9.55% | 9.05% | 8.62% | 8.76% | 9.42% | 10.12% | 9.96% | 9.39% | 9.21% | 9.39% | 9.52% | 9.25% | — | — | — | |||||||
| UnitedHealth Group Inc. | 26.87% | 24.14% | 24.02% | 24.25% | 24.46% | 24.39% | 23.19% | 25.12% | 24.56% | 23.60% | 22.10% | 19.04% | 18.79% | 18.08% | 18.33% | 17.40% | 16.98% | 17.09% | 17.18% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-10-22), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-23).
1 Q2 2020 Calculation
ROE = 100
× (Net earnings attributable to Danaher stockholdersQ2 2020
+ Net earnings attributable to Danaher stockholdersQ1 2020
+ Net earnings attributable to Danaher stockholdersQ4 2019
+ Net earnings attributable to Danaher stockholdersQ3 2019)
÷ Total Danaher stockholders’ equity
= 100 × (927,300 + 595,100 + 1,275,100 + 668,000)
÷ 36,261,700 = 9.56%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Danaher Corp.’s ROE improved from Q4 2019 to Q1 2020 but then deteriorated significantly from Q1 2020 to Q2 2020. |
Return on Assets (ROA)
Danaher Corp., ROA calculation (quarterly data)
| Jul 3, 2020 | Apr 3, 2020 | Dec 31, 2019 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 31, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 31, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Dec 31, 2015 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||||||||||||||||||||||||
| Net earnings attributable to Danaher stockholders | 927,300 | 595,100 | 1,275,100 | 668,000 | 731,300 | 333,800 | 746,800 | 663,700 | 673,800 | 566,600 | 856,600 | 572,100 | 557,300 | 506,100 | 747,000 | 391,600 | 656,700 | 758,400 | 688,600 | 1,403,300 | 695,700 | 569,800 | |||||||
| Total assets | 71,268,400 | 68,930,300 | 62,081,600 | 61,531,100 | 53,322,000 | 51,774,400 | 47,832,500 | 47,719,500 | 48,055,800 | 47,145,200 | 46,648,600 | 45,851,300 | 45,646,800 | 45,245,100 | 45,295,300 | 41,297,500 | 51,503,700 | 48,385,600 | 48,222,200 | 49,707,900 | 36,986,800 | 36,072,300 | |||||||
| Profitability Ratio | |||||||||||||||||||||||||||||
| ROA1 | 4.86% | 4.74% | 4.85% | 4.03% | 4.64% | 4.67% | 5.54% | 5.79% | 5.55% | 5.41% | 5.34% | 5.20% | 4.82% | 5.09% | 5.64% | 6.04% | 6.81% | 7.33% | 6.96% | — | — | — | |||||||
| Benchmarks | |||||||||||||||||||||||||||||
| ROA, Competitors2 | |||||||||||||||||||||||||||||
| Becton, Dickinson & Co. | 2.01% | 1.76% | 2.38% | 1.79% | 2.05% | 1.98% | 0.58% | 1.43% | 0.08% | 0.73% | 2.92% | 2.13% | 5.45% | 5.38% | 3.81% | 4.37% | 3.09% | 2.64% | 2.59% | 3.01% | 3.81% | 6.22% | |||||||
| Boston Scientific Corp. | 12.93% | 14.24% | 15.38% | 4.07% | 5.74% | 7.55% | 7.96% | 3.29% | 2.66% | 0.58% | 0.55% | 4.52% | 4.29% | 2.42% | 1.92% | 0.46% | -1.93% | -0.20% | -1.32% | — | — | — | |||||||
| Intuitive Surgical Inc. | 11.24% | 14.02% | 14.17% | 14.39% | 14.18% | 13.93% | 14.37% | 10.88% | 11.70% | 11.95% | 11.46% | 15.99% | 15.55% | 16.21% | 11.34% | 11.69% | 11.73% | 11.84% | 12.00% | — | — | — | |||||||
| Medtronic PLC | 5.13% | 4.84% | 5.16% | 5.54% | 2.56% | 3.53% | 3.40% | 2.93% | 5.31% | 4.10% | 4.04% | 4.07% | 4.31% | 3.70% | 3.55% | 2.37% | 2.21% | 2.51% | 2.51% | — | — | — | |||||||
| Stryker Corp. | 5.09% | 7.35% | 6.90% | 12.85% | 13.47% | 13.58% | 13.05% | 5.60% | 5.01% | 4.60% | 4.60% | 8.28% | 7.98% | 8.23% | 8.06% | 8.22% | 7.82% | 8.22% | 8.86% | — | — | — | |||||||
| Thermo Fisher Scientific Inc. | 6.02% | 6.25% | 6.33% | 6.33% | 6.11% | 5.71% | 5.22% | 4.66% | 4.32% | 3.98% | 3.93% | 4.16% | 4.87% | 4.70% | 4.40% | 4.16% | 4.73% | 4.64% | 4.83% | — | — | — | |||||||
| UnitedHealth Group Inc. | 8.88% | 7.27% | 7.96% | 7.68% | 7.77% | 7.83% | 7.87% | 8.32% | 7.67% | 7.21% | 7.59% | 6.14% | 5.87% | 5.53% | 5.71% | 5.30% | 5.17% | 5.10% | 5.22% | — | — | — | |||||||
Based on: 10-Q (filing date: 2020-07-23), 10-Q (filing date: 2020-05-06), 10-K (filing date: 2020-02-21), 10-Q (filing date: 2019-10-24), 10-Q (filing date: 2019-07-18), 10-Q (filing date: 2019-04-18), 10-K (filing date: 2019-02-21), 10-Q (filing date: 2018-10-18), 10-Q (filing date: 2018-07-19), 10-Q (filing date: 2018-04-19), 10-K (filing date: 2018-02-21), 10-Q (filing date: 2017-10-19), 10-Q (filing date: 2017-07-20), 10-Q (filing date: 2017-04-20), 10-K (filing date: 2017-02-22), 10-Q (filing date: 2016-10-20), 10-Q (filing date: 2016-07-25), 10-Q (filing date: 2016-04-21), 10-K (filing date: 2016-02-24), 10-Q (filing date: 2015-10-22), 10-Q (filing date: 2015-07-23), 10-Q (filing date: 2015-04-23).
1 Q2 2020 Calculation
ROA = 100
× (Net earnings attributable to Danaher stockholdersQ2 2020
+ Net earnings attributable to Danaher stockholdersQ1 2020
+ Net earnings attributable to Danaher stockholdersQ4 2019
+ Net earnings attributable to Danaher stockholdersQ3 2019)
÷ Total assets
= 100 × (927,300 + 595,100 + 1,275,100 + 668,000)
÷ 71,268,400 = 4.86%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Danaher Corp.’s ROA deteriorated from Q4 2019 to Q1 2020 but then improved from Q1 2020 to Q2 2020 exceeding Q4 2019 level. |